Search research articles
Contact Us
Filters
Showing results (91-100 of 162) with videos related to
Page
of 17
Sort By:
Cardiovascular Diabetology
|
November 29, 2023
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial
Akihiko Koshino, Brendon L Neuen, Niels Jongs, et al.
Kidney International Reports
|
April 18, 2023
Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort
Juan Jose Garcia Sanchez, Glen James, Juan Jesus Carrero, et al.
Advances in Therapy
|
April 18, 2023
The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial
Bartholomeus J A Willigers, Mario Ouwens, Andrew Briggs, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial
David M Charytan, Jie Yu, Meg J Jardine, et al.
Diabetes, Obesity & Metabolism
|
January 9, 2025
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial
Amanda Siriwardana, Luke Buizen, Min Jun, et al.
BMJ Open
|
March 7, 2024
Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications
Mustafa Arici, Samir Helmy Assaad-Khalil, Marcello Casaccia Bertoluci, et al.
Kidney International Reports
|
February 22, 2021
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
Megumi Oshima, Akinori Hara, Tadashi Toyama, et al.
Kidney International Reports
|
May 20, 2024
Framework of Guidelines for Management of CKD in Asia
Carol Pollock, Ju-Young Moon, Le Pham Ngoc Ha, et al.
Contributions to Nephrology
|
June 1, 2011
Outcomes of patients with planned initiation of hemodialysis in the IDEAL trial
John Collins, Bruce Cooper, Pauline Branley, et al.
Kidney International
|
February 17, 2012
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights
Iain C Macdougall, Simon D Roger, Angel de Francisco, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 162) with videos related to
Sort By:
Page
of 17
Cardiovascular Diabetology
|
November 29, 2023
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial
Akihiko Koshino, Brendon L Neuen, Niels Jongs, et al.
Kidney International Reports
|
April 18, 2023
Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort
Juan Jose Garcia Sanchez, Glen James, Juan Jesus Carrero, et al.
Advances in Therapy
|
April 18, 2023
The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial
Bartholomeus J A Willigers, Mario Ouwens, Andrew Briggs, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial
David M Charytan, Jie Yu, Meg J Jardine, et al.
Diabetes, Obesity & Metabolism
|
January 9, 2025
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial
Amanda Siriwardana, Luke Buizen, Min Jun, et al.
BMJ Open
|
March 7, 2024
Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications
Mustafa Arici, Samir Helmy Assaad-Khalil, Marcello Casaccia Bertoluci, et al.
Kidney International Reports
|
February 22, 2021
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
Megumi Oshima, Akinori Hara, Tadashi Toyama, et al.
Kidney International Reports
|
May 20, 2024
Framework of Guidelines for Management of CKD in Asia
Carol Pollock, Ju-Young Moon, Le Pham Ngoc Ha, et al.
Contributions to Nephrology
|
June 1, 2011
Outcomes of patients with planned initiation of hemodialysis in the IDEAL trial
John Collins, Bruce Cooper, Pauline Branley, et al.
Kidney International
|
February 17, 2012
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights
Iain C Macdougall, Simon D Roger, Angel de Francisco, et al.
Page
of 17